Risankizumab for the Treatment of Palmoplantar Pustular Psoriasis: A Report of Two Cases by Luigi Gargiulo, Carlo Alberto Vignoli, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Chiara Perugini

Connect to this object online.

Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience by Luigi Gargiulo, Francesco Piscazzi, Luciano Ibba, Mario Valenti, Paola Facheris, Chiara Perugini, Antonio Costanzo, Alessandra Narcisi

Connect to this object online.

Long-term effectiveness and safety of risankizumab in patients with moderate-to-severe psoriasis with and without cardiometabolic comorbidities: a single-center retrospective study by Luciano Ibba, Sara Di Giulio, Luigi Gargiulo, Paola Facheris, Chiara Perugini, Antonio Costanzo, Alessandra Narcisi, Mario Valenti

Connect to this object online.

Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers by Diego Orsini, Luigi Gargiulo, Luciano Ibba, Ruggero Cascio Ingurgio, Mario Valenti, Chiara Perugini, Alessia Pacifico, Fabio S. Maramao, Pasquale Frascione, Antonio Costanzo, Alessandra Narcisi

Connect to this object online.

Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study by Luigi Gargiulo, Luciano Ibba, Matteo Bianco, Sara Di Giulio, Alfano Alfano, Ruggero Cascio Ingurgio, Paola Facheris, Chiara Perugini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi

Connect to this object online.